Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2000
07/06/2000WO2000039116A1 Aminopyrazole derivatives
07/06/2000WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists
07/06/2000WO2000039113A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
07/06/2000WO2000039111A1 Antithrombotic amides
07/06/2000WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors
07/06/2000WO2000039108A1 Thrombin or factor xa inhibitors
07/06/2000WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000039101A1 Pyrimidine compounds
07/06/2000WO2000039099A1 Benzimidazole derivatives
07/06/2000WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
07/06/2000WO2000039088A1 Glucagon antagonists/inverse agonists
07/06/2000WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
07/06/2000WO2000039083A2 Pyrazole compounds and uses thereof
07/06/2000WO2000039077A2 Thyroid receptor ligands
07/06/2000WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
07/06/2000WO2000038732A1 Hyaluronate lyase used for promoting penetration in topical agents
07/06/2000WO2000038729A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
07/06/2000WO2000038728A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications
07/06/2000WO2000038727A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
07/06/2000WO2000038726A1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
07/06/2000WO2000038725A1 Combinations for cardiovascular indications
07/06/2000WO2000038724A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
07/06/2000WO2000038723A1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
07/06/2000WO2000038722A1 COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
07/06/2000WO2000038721A1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
07/06/2000WO2000038703A1 Agent for treating visual cell function disorder
07/06/2000WO2000038688A1 Medicinal compositions for treatment of atrial fibrillation
07/06/2000WO2000038684A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
07/06/2000WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000038676A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
07/06/2000WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
07/06/2000WO2000038666A2 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
07/06/2000WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes
07/06/2000WO2000038659A1 Transdermal drug delivery system
07/06/2000WO2000038518A1 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
07/06/2000WO2000020025A3 Akt compositions for enhancing survival of cells
07/06/2000WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor
07/06/2000WO2000017222A8 31 human secreted proteins
07/06/2000WO2000015770A3 Human serine/threonine protein kinases
07/06/2000WO2000013703A3 Methods of treating hypertension and compositions for use therein
07/06/2000WO2000013686A3 Sustained release ranolazine formulations
07/06/2000WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000DE19928528A1 Well tolerated herbal antiarteriosclerotic medicament for combating arterial blood flow deficiency sequelae, comprising capsule containing Ginkgo biloba, Ammi visnaga and Allium sativum components
07/06/2000CA2363999A1 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
07/06/2000CA2361149A1 Aromatic amides
07/06/2000CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
07/06/2000CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
07/06/2000CA2358091A1 Antithrombotic amides
07/06/2000CA2358067A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
07/06/2000CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds
07/06/2000CA2356692A1 Hydrophilic ampholytic polymer
07/06/2000CA2356664A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
07/06/2000CA2356622A1 Compounds which affect mrna stability and uses therefor
07/06/2000CA2356607A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
07/06/2000CA2356551A1 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
07/06/2000CA2356515A1 Combinations for cardiovascular indications
07/06/2000CA2356382A1 Agent for treating visual cell function disorder
07/06/2000CA2356319A1 Thyroid receptor ligands
07/06/2000CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes
07/06/2000CA2356156A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications
07/06/2000CA2355281A1 Thrombin inhibitors
07/06/2000CA2354053A1 A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
07/06/2000CA2352896A1 Pyrimidine compounds
07/06/2000CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates
07/06/2000CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
07/06/2000CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
07/06/2000CA2349557A1 Thrombin or factor xa inhibitors
07/06/2000CA2348740A1 Thrombin or factor xa inhibitors
07/06/2000CA2321672A1 Caspase-8 interacting proteins
07/06/2000CA2320730A1 Thrombin or factor xa inhibitors
07/06/2000CA2318356A1 Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin
07/05/2000EP1016411A1 Sulodexide for restenosis therapy
07/05/2000EP1015604A1 Human prl-1 phosphatase
07/05/2000EP1015586A2 Tie receptor tyrosine kinase ligand homologues
07/05/2000EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells
07/05/2000EP1015566A1 Human ste20-like stress activated serine/threonine kinase
07/05/2000EP1015490A1 No-modified hemoglobins and uses therefor
07/05/2000EP1015471A1 Hypoxia-regulated genes
07/05/2000EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives
07/05/2000EP1015451A1 Tetrahydro gamma-carbolines
07/05/2000EP1015449A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors
07/05/2000EP1015443A1 Thromboxane ligands
07/05/2000EP1015439A1 Prenyl transferase inhibitors
07/05/2000EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
07/05/2000EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
07/05/2000EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments
07/05/2000EP1015007A1 Analogs of peptide yy and uses thereof
07/05/2000EP1015006A2 Cocoa extract compounds and methods for making and using the same
07/05/2000EP1014995A1 Compositions and methods for preventing restenosis following revascularization procedures
07/05/2000EP1014989A1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation
07/05/2000EP1014987A1 Oral compositions of levosimendan
07/05/2000EP1014984A1 Inhibitors of prenyl-protein transferase
07/05/2000EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
07/05/2000EP1014976A1 Novel substituted imidazole compounds
07/05/2000EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
07/05/2000EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
07/05/2000EP0736018B1 4,5-diaryloxazole derivatives
07/05/2000EP0734381B1 Morpholine tachykinin receptor antagonists
07/05/2000EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications
1 ... 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 ... 1595